Complex Molecular Etiology and Cellular Landscape of Hip Osteoarthritis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-74
SponsorUniversity of Turku
About this trial
The purpose of this study is to cast light on the highly complex etiology and cellular landscape of hip osteoarthritis by utilising single-cell and spatial omics.
Eligibility criteria
Qualifiers
None
Disqualifiers
The body mass index must be below 35
Age < 18 or > 74
The OA patients may not have diabetes, rheumatoid arthritis (RA), or metabolic syndrome.
Trial design
Treatments tested in this trial
- Total hip arthroplasty
Treatment groups
110 Participants
are divided into 3 treatment groupsSponsors and collaborators
University of Turku
Lead sponsor
Turku University Hospital
Collaborator
Hospital District of Helsinki and Uusimaa
Collaborator
Source ClinicalTrials.gov